Crossmark

Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome

Crossref DOI link: https://doi.org/10.1038/s41375-018-0350-3

Published Online: 2019-01-16

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ribezzo, Flavia

Snoeren, Inge A. M.

Ziegler, Susanne

Stoelben, Jacques

Olofsen, Patricia A.

Henic, Almira

Ferreira, Monica Ventura

Chen, Si

Stalmann, Ursula S. A.

Buesche, Guntram

Hoogenboezem, Remco M.

Kramann, Rafael

Platzbecker, Uwe

Raaijmakers, Marc H. G. P.

Ebert, Benjamin L.

Schneider, Rebekka K.
Funding

Funding for this research was provided by:

KWF Kankerbestrijding (11031/2017-1)

EC | European Research Council (ERC-StG 757339)

European Hematology Association (John Goldman Clinical Research grant)
License Information

Text and Data Mining valid from 2019-01-16
More Information

Article History

Received: 3 July 2018

Revised: 13 November 2018

Accepted: 28 November 2018

First Online: 16 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.